Morocco’s Minister of Health and Social Protection, Amine El Haeroui, announced a revised drug regulation law, bill 27.26, amending law 17.04. The amendment aims to bolster the national health system by improving the quality and safety of pharmaceuticals and health products. The updated legislation seeks to align Moroccan legal frameworks with international standards, particularly regarding the roles of regulatory bodies. A key focus of the changes is increased vigilance against counterfeit and substandard medications. This revision represents ongoing efforts to enhance public health and ensure access to reliable medicinal products within the country. The new law intends to reinforce controls and oversight throughout the pharmaceutical supply chain.